106 related articles for article (PubMed ID: 24981127)
1. Stromal cell-derived factor 1-induced osteoclast differentiation independent of RANKL: comment on the article by Kim et al.
Ji JD
Arthritis Rheumatol; 2014 Oct; 66(10):2911. PubMed ID: 24981127
[No Abstract] [Full Text] [Related]
2. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Jung HG; Cho ML; Lee SH
Arthritis Rheumatol; 2014 Mar; 66(3):538-48. PubMed ID: 24574213
[TBL] [Abstract][Full Text] [Related]
3. RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.
Danks L; Komatsu N; Guerrini MM; Sawa S; Armaka M; Kollias G; Nakashima T; Takayanagi H
Ann Rheum Dis; 2016 Jun; 75(6):1187-95. PubMed ID: 26025971
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.
Bradfield PF; Amft N; Vernon-Wilson E; Exley AE; Parsonage G; Rainger GE; Nash GB; Thomas AM; Simmons DL; Salmon M; Buckley CD
Arthritis Rheum; 2003 Sep; 48(9):2472-82. PubMed ID: 13130466
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
[TBL] [Abstract][Full Text] [Related]
7. Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
Catrina AI; Klareskog L
Arthritis Rheum; 2008 Nov; 59(11):1685; author reply 1685-6. PubMed ID: 18975354
[No Abstract] [Full Text] [Related]
8. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
[TBL] [Abstract][Full Text] [Related]
9. IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis.
Park MK; Her YM; Cho ML; Oh HJ; Park EM; Kwok SK; Ju JH; Park KS; Min DS; Kim HY; Park SH
Immunol Lett; 2011 Sep; 139(1-2):42-51. PubMed ID: 21620893
[TBL] [Abstract][Full Text] [Related]
10. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
Nakano K; Okada Y; Saito K; Tanaka Y
Arthritis Rheum; 2004 Aug; 50(8):2450-8. PubMed ID: 15334457
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanism of osteoclastogenesis in rheumatoid arthritis.
Udagawa N; Kotake S; Kamatani N; Takahashi N; Suda T
Arthritis Res; 2002; 4(5):281-9. PubMed ID: 12223101
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
[TBL] [Abstract][Full Text] [Related]
13. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
[TBL] [Abstract][Full Text] [Related]
14. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
15. CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway.
Li CH; Xu LL; Zhao JX; Sun L; Yao ZQ; Deng XL; Liu R; Yang L; Xing R; Liu XY
Inflamm Res; 2016 Mar; 65(3):193-202. PubMed ID: 26621504
[TBL] [Abstract][Full Text] [Related]
16. [RANKL/RANK signaling in rheumatoid arthritis].
Omata Y; Tanaka S
Clin Calcium; 2011 Aug; 21(8):1175-80. PubMed ID: 21814022
[TBL] [Abstract][Full Text] [Related]
17. What is the rank of RANKL in spondylarthritis?
Loddenkemper K; Burmester GR
Arthritis Rheum; 2008 Mar; 58(3):641-4. PubMed ID: 18311809
[No Abstract] [Full Text] [Related]
18. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts.
Hitchon C; Wong K; Ma G; Reed J; Lyttle D; El-Gabalawy H
Arthritis Rheum; 2002 Oct; 46(10):2587-97. PubMed ID: 12384916
[TBL] [Abstract][Full Text] [Related]
20. Erosive arthritis.
Schett G
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S2. PubMed ID: 17634141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]